Cardiovascular Systems Inc

Cardiovascular Systems is a medical technology company. The company has developed an orbital atherectomy systems (OAS) for both peripheral and coronary commercial applications. The primary base of the company's business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. The company's products include its coronary arterial disease (CAD) product, the Diamondback 360 Coronary OAS, which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
  • TickerCSII
  • ISINUS1416191062
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

ValuEngine Rating and Forecast Report for CSII

MarketLine Department

VentriPoint Diagnostics Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's VentriPoint Diagnostics Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by VentriPoint Diagnostics Ltd. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its compe...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Consumer Cyclical names continue to reflect leadership. (ex. SBUX, RRGB, MCD, PZZA, and ROST.) • The Financial Sector has a number of attractive names developing major bases and staging RS reversals. (ex. SIVB, STT, AXP, SPGI, CME, GS, and JEF) • The Technology Sector has a number of technically attractive constituents. (ex. AMD, OLED, MPWR, CRUS, BR, FIS, VRSN, SAIC, LDOS, AAOI, BELFB, FARO, STX, and AAPL) .

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

U.S. dollar breaking down; Gold breaking out The S&P 500 is consolidating under 2,954 - logical resistance - as market participants are in wait-and-see mode for incremental trade news ahead of the Trump/Xi G20 meeting later this week. While a breakout is certainly possible, we believe additional consolidation is the more likely scenario. Below we highlight a mix of positive and negative developments which lead us to this conclusion along with updates on other big picture trends. • U.S. dollar (DXY) breaking down, Treasury yields remain suppressed. Dovish Fed comments opened the door for rate...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Small-caps, biotech, Discretionary hitting new highs We remain bullish on the market, but to be clear, this is not a blanket endorsement. As we outline below, the “market” has pockets of strength and pockets of weakness. Our aim as always, is to highlight each and guide our clients to areas of outperformance. With that said, let's consider the weight of the evidence for the current state of our market and our bullish recommendation. • Positives. Helping support the bull case are a number of things we would not expect to see if there was trouble ahead for the market: (1) the Russell 2000 smal...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

• U.S. equity markets remain resilient. As global equity markets recover from Italian political risk, the U.S. has reasserted itself as leadership. Led by strength in technology and biotech, the Nasdaq hit a new all-time high yesterday. Small-cap indexes are also hitting all-time highs. Moreover, the S&P 500 has moved to a new high relative to May prices, providing new evidence that the market is likely to continue its trend higher. Given these developments, our outlook continues to move toward the bullish camp... see below. • Sector Relative Strength Rankings. Equal-weighted Health Care mai...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch